China SXT Pharmaceuticals (SXTC) Short-term Investments (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Short-term Investments of $368.0 for Q1 2026, down 98.79% year-over-year from $30413.0 in Q1 2025, and down 98.81% quarter-over-quarter from $31001.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Short-term Investments (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Short-term Investments history runs 7 years deep, the most recent figure standing at $368.0 for Q1 2026.
- In Q1 2026, Short-term Investments fell 98.79% year-over-year to $368.0; the TTM figure through Mar 2026 stood at $368.0 (down 98.79% YoY), while the FY2026 annual figure was $368.0, down 98.79% from the prior year.
- Short-term Investments for Q1 2026 stood at $368.0, down from $31001.0 in the prior quarter.
- The five-year high for Short-term Investments was $45297.0 in Q1 2022, with the low at $368.0 in Q1 2026.
- The 4-year median for Short-term Investments is $30413.0 (2025), against an average of $22784.2.
- The sharpest annual moves came in 2025 and 2026: Short-term Investments surged 344.5% in 2025, then tumbled 98.79% in 2026.
- China SXT Pharmaceuticals' Short-term Investments stood at $45297.0 in 2022, then tumbled by 84.9% to $6842.0 in 2024, then jumped by 353.1% to $31001.0 in 2025, then tumbled by 98.81% to $368.0 in 2026.
- Business Quant data shows SXTC's Short-term Investments at $368.0 in Q1 2026, $31001.0 in Q3 2025, and $30413.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | China SXT Pharmaceuticals | 33,256.74 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 368.00 |
| Sep 30, 2025 | 31,001.00 |
| Mar 31, 2025 | 30,413.00 |
| Mar 31, 2024 | 6,842.00 |
| Mar 31, 2022 | 45,297.00 |
| Mar 31, 2021 | 25,947.00 |
| Sep 30, 2019 | 77,158.00 |
| Mar 31, 2019 | 161,084.00 |
| Sep 30, 2018 | 182,203.00 |
| Mar 31, 2018 | 97,515.00 |